Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34343032

Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Sep 20
First author
Defachelles AS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Sep 20;39(27):2977-2978. doi: 10.1200/JCO.21.01631.
    note
    Source null
    related pmid
    34383578
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2022 Mar 20;40(9):1030. doi: 10.1200/JCO.21.02173.
    note
    Source null
    related pmid
    35130026
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2022 Mar 20;40(9):1030-1032. doi: 10.1200/JCO.21.02612.
    note
    Source null
    related pmid
    35130027
    relationship
    Comment in

Authors and identifiers

  1. name
    Defachelles AS
    type
    Author
  2. name
    Bogart E
    type
    Author
  3. name
    Casanova M
    type
    Author
  4. name
    Merks JHM
    type
    Author
  5. name
    Bisogno G
    type
    Author
  6. name
    Calareso G
    type
    Author
  7. name
    Gallego Melcon S
    type
    Author
  8. name
    Gatz SA
    type
    Author
  9. name
    Le Deley MC
    type
    Author
  10. name
    McHugh K
    type
    Author
  11. name
    Probst A
    type
    Author
  12. name
    Rocourt N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Defachelles AS
    type
    Author
  2. name
    Bogart E
    type
    Author
  3. name
    Casanova M
    type
    Author
  4. name
    Merks JHM
    type
    Author
  5. name
    Bisogno G
    type
    Author
  6. name
    Calareso G
    type
    Author
  7. name
    Gallego Melcon S
    type
    Author
  8. name
    Gatz SA
    type
    Author
  9. name
    Le Deley MC
    type
    Author
  10. name
    McHugh K
    type
    Author
  11. name
    Probst A
    type
    Author
  12. name
    Rocourt N
    type
    Author
bibliography ids
  1. nci-bib-4d00bf7430852267085ac4d4
book metadata
content sha256
c868f90eb5e237e0e875f57b73865b4ca18112d5f04b8c224aece13d458c7de6
document type
citation
dois
  1. 10.1200/JCO.21.00124
electronic publication date
display
2021 Aug 3
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34343032
immutable id
pubmed:34343032@c868f90eb5e237e0e875f57b73865b4ca18112d5f04b8c224aece13d458c7de6
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
27
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2979-2990
volume
39
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Sep 20;39(27):2977-2978. doi: 10.1200/JCO.21.01631.
    note
    Source null
    related pmid
    34383578
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2022 Mar 20;40(9):1030. doi: 10.1200/JCO.21.02173.
    note
    Source null
    related pmid
    35130026
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2022 Mar 20;40(9):1030-1032. doi: 10.1200/JCO.21.02612.
    note
    Source null
    related pmid
    35130027
    relationship
    Comment in
outcomes validated
false
pmid
34343032
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
dbb930676aecf8539e4a1d07b45bb1d0131638b8074472aae67936854505306f
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Sep 20
precision
day
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34343032/
title
Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial.

Preserved source evidence · Not medical advice